Hosting Organization
Operating Organization


Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision

BIT Lifesciences, Inc.
Supporting Organization
International Marketing Partner

Participants List
(Academia)

National Yang-Ming University, Taiwan

Abyad Medical Center and Middle-East Longevity Institute, Lebanon

Akershus University Hospital, Norway

Aligarh M University, India

American University of Beirut, USA

Antwerp University Hospital, Belgium

Applied Proteomics and Molecular Medicine, USA

Aristotelian University of Thessaloniki, Greece

Banaras Hindu University, India

Barrow Neurological Institute, USA

Baylor College of Medicine, USA

Ben-Gurion University of the Negev, Israel

Boston University School of Medicine, USA

Cancer Research Technology, UK

CHDI Foundation, California

Chinese Academy of Sciences, China

CRG-Centre de Regulaci Genmica, Spain

CSIRO Molecular and Health Technologies, Australia

Duke University, USA

Emory University, USA

exas Southern University, USA

Florida A&M University, USA

Global Pathology Support, The Netherlands

Gujarat AIDS Awareness and Prevention Unit, India

Haematopoietic Stem Cell Laboratory, UK

Harvard Medical School, USA

Hospital S Hospital S Joao, Portugal

Human BioMolecular Re-. search Institute, USA

Indiana University School of Medicine, USA

Indiana University School of Medicine, USA

Innsbruck Medical University, Austria

Institute of Experimental Pharmacology, Slovak

Instituto De Biologia Experimentale Tecnologica, Portugal

Karolinska Institutet, Sweden

Keystone College Academia, USA

McGill University, Canada

Mercer University, USA

National Center for Toxicological Research, USA

National Institutes of Health, USA

Netherlands Cancer Institute, The Netherlands
New York Medical College, USA

Osaka University, Japan

Paul-Ehrlich-Institute, Germany

Penn State College of Medicine, USA

Pennsylvania State University College of Medicine, USA

Pharmacology Temple University, USA

Scientific Advisory Board Tolerx, USA 

Shanghai Unviversity of Traditional Chinese Medicine, China

Solid Tumor Working Party, Italy

Stanford University, USA

Structural Genomics Consortium Karolinska Institutet, Sweden

Tabriz University of Medical Sciences, Iran

Technion - Israel Institute of Technology Rappaport Institute, Israel

The Babraham Institute, UK

The Hebrew University, Israel

The Institute of Cancer Research, UK

The University of Queensland, Australia

The University of Sydney, Australia

The University of Texas, USA

UC College of Medicine, USA

Universidade Federal Fluminense, Brazil

University Clinic Bonn, Germany

University of Basel, Switzerland

University of British Columbia, Canada

University of California, USA

University of California-San Francisco, USA

University of Camerino, Italy

University of Cape Town, USA

University of Colorado Health Sciences Center, USA

University of Crete, Greece

University of Geneva, Switzerland

University of Heidelberg, Germany

University of Hong Kong, China

University of Maryland School of Pharmacy, USA

University of Maryland, USA

University of Massachusetts Medical School, USA

University of Miami School of Medicine, USA

University of Miami, USA

University of Miami, USA

University of Oklahoma Health Sciences Center, USA

University of Siena, Italy

University of Southern Denmark, Denmark

University of Texas at Dallas, USA

University of Texas Health Science Center, USA

University of Texas Medical, USA

University of the Sciences in Philadelphia, USA

University of Utah School of Medicine, USA

University of Western Australia, Australia

Utah State University, USA

Virginia Commonwealth University, USA

University of Gothenburg, Sweden


Participants List
(Business)

3 P Biopharmaceuticals, USA

Abbott Laboratories, USA

Adolor Corporation, USA

Affimed Therapeutics AG, Germany

AILERON Therapeutics, USA

Algorithme Pharma Inc., Canada

Allon Therapeutics Inc., USA

Alpha Cancer Technologies Inc., USA

Alpha-2 Pharmaceutica AB, Israel

Amgen, Inc., USA

Arena Pharmaceuticals, USA

Astellas Pharma Inc, Japan

Astellas Pharmaceutical Inc., Japan

AstraZeneca Pharmaceuticals, USA

AstraZeneca R&D Molndal, Sweden

Astrazeneca R&D Sodertolje, Sweden

AstraZeneca, UK

AstraZeneca, USA

AuxoCell Laboratories, Inc., USA

Avexa Ltd, Australia

Bayer HealthCare, USA

Bayer Schering Pharma AG, Germany

BellBrook Labs, LLC, USA

Biological Mimetics, Inc., USA

BioPerspectives, USA

Biota Holdings Limited, USA

Boehringer Ingelheim Pharmaceuticals, Inc., USA

Bristol-Myers Squibbs, USA

Centocor/Johnson & Johnson, USA

Chemistry Forma Therapeutics, Inc., Singapore

Coley Pharmaceutical GmbH, Germany

Cordex Pharma, Inc., USA

Cornerstone Pharmaceuticals, USA

Covidien, USA

Daiichi Sankyo Pharma Development, Japan

deCODE Chemistry, USA

DxS Ltd, USA

Eisai Co., Ltd., Japan

Elan Pharmaceuticals, USA

Europe GlaxoSmithKline R&D, UK

Genentech, USA

Genetix Ltd, UK

genscript, USA

Genzyme Pharmaceuticals, USA

Gilead Sciences Benzothiadiazine Hepatitis C NS5B, USA

Hoffmann-La Roche, Switzerland
ICON PLC, USA

IDDC Corporation, USA

Idera Pharmaceuticals, USA

Jesus College, England

Johnson & Johnson Pharmaceutical, USA

Johnson & Johnson Research Pty Limited, Australia

Laboratory Cellular Technology Ltd., USA

Lundbeck Research, USA

Mallinckrodt, Inc., USA

MDS Pharma Services, USA

Medimmune, UK

Merck & Co. Inc, USA

Merck & Co., Italy

Merck and Co., Inc., China

Merck KGaA, Germany

Merck Research Laboratories, USA

Nerviano Medical Sciences, Italy

Novartis Institutes for Biomedical Research, USA

Novartis Institutes, Switzerland

Novartis Pharmaceuticals Corporation, USA

Novartis, China

Ocimum Biosolutions, India

Ondokuz Mayis University, Turkey

OphthalmoPharma, Switzerland
Pfizer, USA

Pharmanet Development Group, Inc., USA

PharmaNet, Inc., USA

Ranbaxy Laboratories Limited, India

Reaction Biology Corporation, USA

RegPak BioPharma Consulting, The Netherlands

Sanofi Aventis, USA

Schering Plough Research Institute, USA

Schlich & Co, UK

Scott & White, USA

Sequoia Pharmaceuticals Inc., USA

SeraCare Life Sciences, USA

Shanghai Biochip Co., Ltd, China

Shenogen Pharma Group, China

Siena Biotech S.p.A. A company, USA

Simulations Plus, Inc., USA

Synta Pharmaceuticals Corp, USA

TEVA Pharmaceuticals, USA

The Takeda Oncology Company, USA

ThromboGenics, USA

Transgene, France

US Oncology Research, Inc., USA

Vaxinnate, USA

Wyeth Research, USA 

XOMA (US) LLC, USA

Zeptosens C a Division of Bayer (Schweiz) AG, Switzerland

Zhejiang Hisun Pharmaceutical Co., Ltd, China

Tehran University of Medical Sciences , Iran


CMBF 2009
(Aug. 8-10, 2009, Dalian, China)
RMSC 2009
(Aug. 8-10, 2009, Dalian, China)
IDDST 2009
(Oct.22-25, 2009, Shanghai, China)
 
CEMD 2009
(Nov.19-21, 2009, Beijing, China)
WCG 2009
(December 1-7, 2009, Foshan, China)
 
ICC 2009
(Dec. 5-7, 2009, Shanghai, China)
Pepcon 2010
(March 21-23, 2010, Beijing, China)
ICA 2010
(March 24-26, 2010, Beijing, China)
WCV 2010
(March 24-26, 2010, Beijing, China)
SEB 2010
(Apr. 22-24, 2010, Shanghai, China)
WCC-Breast Cancer 2010
Tri-Breast Cancer Conference

(Apr. 25-27, 2010, Shanghai, China)
WCIT 2010
(May 15-18, 2010, Beijing, China)
ICM 2010
(May 18-20, 2010, Beijing, China)
WCCAS 2010
(May 19-21, 2010, Beijing, China )
IBIO 2010
(July 25-27, 2010, Qingdao, China)
WCVI-2010
(July 31-August 3, 2010, Korea)
 
 

NO.1
GL Biochem (Shanghai) Ltd.

GL Biochem (Shanghai) Ltd. is a leading manufacturer of peptides、peptides reagents、 building blocks and antibody and has the most diverse in-house made product line in China.
Since our inception in 1998, GL Biochem has been experiencing tremendous growth as a world leading producer of custom peptides. Among nearly 1000 dedicated GL employees, about 360 chemists are directly involved in peptide synthesis, with additional 90 technicians in HPLC purification. GL Biochem already has the biggest custom peptide synthesis capacity in the world with 10000 research grade peptides per month production scale.

NO.2
Viva Biotech Ltd.

Viva Biotech, a Contract Research Organization (CRO), is dedicated to providing drug discovery biology service to global pharmaceutical and biotech companies.
Viva has a team of leading scientists in drug discovery industry, many with over 10 years pharmaceutical and drug discovery experience in senior positions within companies such as Pfizer, Charles River, Millennium, Arqule, Enanta, and Abbott, and at premier academic institutions such as Harvard, Stanford, Cornell, Duke, Hughes Institute and the Burnham Institute.
With our experienced team and efficient technology platforms, Viva is your partner for increasing efficiency and cutting the cost of drug discovery. Viva, with strong financial backing, is strategically located in the world-renowned biotech and pharmaceutical base, Zhangjiang high-tech industrial park, Shanghai, China.
Viva aims to provide biology focused services supporting drug discovery and deliberately has no internal drug discovery activities to avoid any conflict of interest with its clients.

NO.5
BGI Shenzhen

The Beijing Genomics Institute (BGI) was founded in Beijing on Sept 9th, 1999 with the mission of supporting the development of science and technology, building strong research teams, and promoting the development of commercial scientific services.
With a goal toward excellence, high efficiency, and accuracy, BGI has successfully completed a large number of projects. These include sequencing 1% of the human genome for the International Human Genome Project, contributing 10% to the International Human HapMap Project, carrying out research to combat SARS, being a key player in the Sino-British Chicken Genome Project, and completely sequencing the rice genome, the silkworm genome, and, most recently, the first Asian diploid genome. In conjunction with carrying out these projects, BGI has established its own technical platforms based on large-scale genome sequencing, efficient bioinformatics analyses, and innovative genetic health care initiatives. These distinguished achievements have made a great contribution to the development of genomics in both China and the world, and have established BGI as a world-class research institution. In aiming for and attaining these goals, BGI has become the number one genomics institute in Asia and the third largest genomics institute in the world.

NO.7
Cambridge Crystallographic Data Centre
The Cambridge Crystallographic Data Centre (CCDC) provides invaluable structural knowledge to the scientific community, both for academic research, teaching and the pharmaceutical and chemical industries. A registered charity and not-for-profit organisation, CCDC curates the ever growing database of small molecule experimental crystal structures, the Cambridge Structural Database (CSD). With over 40 years of scientific expertise, the CCDC’s software and database tools benefit a broad spectrum of users in research, development, cheminformatics, bioinformatics and teaching.

NO.8
Shanghai Wellson Biotech Co., Ltd.
Founded in 2000, DiscoveRx is a company headquartered in California with offices in England, Germany, and France. DiscoveRx is dedicated to the development and commercialization of innovative solutions for discovery research. DiscoveRx assay solutions are based on our core proprietary Enzyme Fragment Complementation (EFC) technology that is well established in clinical diagnostics and now further enhanced to provide unique solutions to drug discovery research. EFC technology is a proven, established screening technology in most major pharmaceutical companies and our EFC-based HitHunter™ cAMP assays are the market leader in GPCR screening applications. PathHunter™ technology, an adaptation of EFC technology, is an innovative and comprehensive assay system that enables live cell-based assays for pathway profiling and screening. Through our core HitHunter™, PathHunter™, and EFC technologies, DiscoveRx is able to offer assay solutions for every major class of drug target, including GPCRs, kinases, proteases, nuclear hormone receptors, transcription factors, and secreted proteins. DiscoveRx remains committed to fully exploit the commercial potential of its EFC technology either solely or with its corporate partners. DiscoveRx has partnerships with leading life sciences organizations, such as, Merck,GlaxoSmithKline,Roche,Schering Plough,Janssen, and co-marketing with Caliper Life Sciences for our PathHunter eXpress products. DiscoveRx values such patnerships and is actively seeking additional collaborative alliances to commercialize and provide early access to new technology platforms in the drug discovery and development markets.

NO.9
Araclon Biotech, S.L.., Spain
Araclon Biotech is a private company devoted to research and development of therapies and diagnostic methods for degenerative diseases, with a special emphasis on Alzheimer’s disease (AD).
The company’s objectives are the international commercialization of a highly sensitive blood test to help physicians to diagnose AD and the development of an effective therapy against AD.
Araclon Biotech´s ABtest® ELISAs are colorimetric assays to discriminate between Alzheimer Disease, Mild Cognitive Impairment and non demented individuals. They are supported by fully developed and simple to use protocols. Many medical and research & development laboratories will be able to work with them.
The company is currently open for partnership to worldwide bring the product to the market.

NO.10
AstaTech(Chengdu)Pharmaceutical Co., Ltd.
AstaTech Chengdu is a wholly owned subsidiary of AstaTech, Inc. (USA). The company was established in 2001 in Chengdu's Hi-tech Development Zone. It serves as AstaTech, Inc.'s Chinese R&D base. AstaTech Chengdu's primary activities area, key intermediate custom synthesis and new product development. AstaTech Chengdu specializes in chiral technologies such as asymmetric synthesis and enzyme-assisted synthesis.

NO.11
Genscript Corporation
GenScript is dedicated to serving pharmaceutical, biotech, and academic customers in the areas of drug discovery, development and life science research. With a global presence and local access, GenScript provides high-quality biology CRO services and around-the-clock account support to our customers all over the world.

NO.12
Colorcor China
Colorcon is a global company that develops, manufactures and supplies specialty chemicals and excipients for the pharmaceutical industry. Our core business is the design and technical support of advanced coating systems for pharmaceutical dosage forms for immediate, sustained and enteric release. In addition, the company's technological capabilities include assistance in the development of solid dosage formulations. Colorcon, Inc. is a global Leaders in Pharmaceutical Technology,We have positioned our business offices, manufacturing facilities and technical service laboratories in strategic locations around the world. This global network ensures the fast, timely access to the products and services that customers demand today.
As an industry leader, Colorcon also makes a point of sharing its expertise through a variety of ongoing educational courses, seminars and symposiums. To help our customers succeed in the highly competitive and increasingly global pharmaceutical market. Our best-of-class technologies are complemented by our values-added services,including technical service,global regulatory information and independent research support.

NO.13
IDEX Health & Science
IDEX Health & Science manufactures Innovadyne high precision, non-contact, liquid-handling instrument platforms; the Nanodrop, Screenmaker, and Platemaker for Drug Discovery, Genomics, and Proteomics. These easily integrated devices are used in laboratories worldwide for HTS, Assay Development, Protein Crystallography, PCR, sequencing, and MALDI applications and come with easy-to-use, state-of-the-art .NET software.

NO.14
Founder International Inc.
Founder International is a wholly-owned subsidiary of Founder Group which was established in 1986, as one of the most significant IT solution providers in China. Founder International has committed to technological innovation and continued to play a vital role in the IT research & development landscape.
Life Science Informatics (LSI) of Founder International is a professional bioinformatics and cheminformatics solution provider. We create values for customers in the industry of CRO, Pharmaceuticals, Chemicals and Life Science Research Institutes with the innovative ideas, as well as providing customized development and consulting service.
It is more cost-effective to introduce specialized information management applications in Life Science industry, instead of the traditional paper work and office automation tools for R&D and project process management. With sophisticated bio-chemists, experienced software engineers and solid foundation of Founder’s IT research & development capabilities, LSI is able to develop the cutting-edge customized Bioinformatics & Cheminformatics systems, which are integrated with the overseas partners’ technologies (CLCbio, ChemAxon & Agilent), and based on chemical structure edition, searching, sorting, genomics/DNA/RNA/Protein analysis & research and electronic laboratory notebook, etc. LSI of Founder International, as China’s leading Bio- & Chem-informatics service provider, is bringing versatile Life Science Informatics Solutions, and delivering best value to you.

NO.15
LABCHINA CO., LIMITED
LabChina Co., Ltd. was established in 2003 and specializes in the distribution of top end laboratory equipment and consumables to the research and industrial markets.
Our head office is in Guangzhou and we have branches in Beijing, Shanghai, Xian, Hong Kong. We have an office in Taipei to service the Taiwan market. Our sub-branches are situated in  Shenzhen, Wuhan, Changsha, Fuzhou, Hangzhou and Nanjing and we also work through an extensive network of sub-distributors effectively covering the whole of the PRC.
All the product we sell are backed by full service and technical support.   LabChina is the exclusive distributor for Biospacelab imaging systems for the PRC and Taiwan. This product range consists of state of the art, radio active and non radioactive imaging instruments, some with patented features.  Some application fields of these products include pharmacokinetics, cancer research, medicine, cosmetology, environmental/ biodiversity, infectious disease, stem cell, genomics, neuroscience and cardiovascular research, to name a few.
We stand by our motto “Only our customers are better than our products”

NO.16
CHINA-JAPAN FEID UNION CO., LTD.
With 22 studies conducted, Tian Xian Liquid is proved it can regulate immune system, suppress the growth of cancerous cells, prevent re-occur and metastasis, suppress cancer stem cells, multi-target and reversion of multi-drug resistance, as a good supplement to helpful auxiliary with general treatments. 

NO.17
Quantum Design Scientific Instrumentation Trading (Beijing) Co., Ltd.
Quantum Design is a privately held corporation that develops and markets advanced technology systems and instruments.  Worldwide, Quantum Design has become the leading commercial source for integrated laboratory analytical systems. With the QD-LOT merger in 2007, Quantum Design established its strong branches in most of European countries. Since then, together with its strong European subsidiaries, Asian subsidiaries, Quantum Design is creating a global network offering distribution and after-sales service to manufacturers of scientific and industrial equipments.
Products in Biological Area: Automated Patch Clamp, Cell Metabolic Activity Analyzing System, CO2 Microscope Incubators; Microfluidics Platform ; Desk-top SEM; Desk-top Stemcell division system

NO.18
Simulations Plus, Inc.
Simulations Plus is a leading developer of simulation and modeling software for the pharmaceutical industry.  We currently offer four products for pharmaceutical research: ADMET Predictor™, ClassPharmer™, DDDPlus™, and GastroPlus™.
ADMET Predictor predicts a variety of properties of chemical compounds from their molecular structures and has been ranked #1 in every comparison study with other commercial predictive software.  Integrated into ADMET Predictor is ADMET Modeler, which creates the predictive models. This advanced, proprietary program includes state-of-the-art technologies for machine learning.
ClassPharmer generates classes of molecules based on the largest common set of connected atoms (“scaffold”) in each class. Recent additions to ClassPharmer have moved it into the realm of a molecule design tool, accomplished via integration of algorithms that generate new molecular structures with ADMET Predictor to evaluate the new structures.
DDDPlus simulates how tablets and capsules disintegrate and dissolve during in vitro dissolution experiments.
GastroPlus, the company’s flagship product, simulates absorption, pharmacokinetics, and pharmacodynamics of potential new drugs. Its powerful PBPK simulations enable researchers to predict the amount of drug that reaches different body tissues and organs. Its ability to deal with a variety of oral dosage forms and controlled release capabilities is unmatched.
Simulations Plus also provides consulting services.

NO.19
Gene Company Limited
Gene Company Limited was founded in August 1992 in Hong Kong by a group of enthusiastic biotechnologists. Our scope of business can be categorized into two main areas; (a) distribution of full range molecular and cell biology instrumentation, reagents and consumables; and (b) consultation services on research projects and experimental techniques. By Now, Gene prides itself as being one of the leading distributors for biotechnology products,e.g. Affymetrix, Applied Imaging, Corbett Research, Dako, Li-Cor and Biotage and has successfully become one of the major research product suppliers to major genomics, proteomics, biochip and stem cell research centres in China. Gene is a wholly-owned subsidiary of Gene Group Holdings Limited in Hong Kong. Apart from distribution activities, the Group is also engaged in biotech products R&D and manufacturing, as well as Traditional Chinese Medicine (TCM) technology development.

NO.20
Promega (Beijing) Biotech Co., Ltd.
Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry.  The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification.  Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors.  For more information about
Promega, visit www.promega.com.

NO.21
SAGE Publications, Inc.
SAGE is one of the leading publishers of humanities, social sciences and STM journals. SAGE continues to be privately and independently
owned and we have 4 regional offices globally. 
SAGE publishes well known journals such as the American Journal of Sports Medicine, Urban Studies, Journal of Composite Materials,
Journal of Communication Research, Neurorehabilitation & Neural Repair, The Counseling Psychologists, Social Studies of Science, 
Crime & Delinquency amongst others.
SAGE Asia-Pacific was established in September 2006 in Singapore and we have 4 regional offices throughout Asia-Pacific. SAGE Asia-Pacific
journal team focuses on ensuring that our e-content reaches most researchers, graduates and undergraduates. We also welcome opportunities 
to explore other partnership arrangements such as publishing journals, translating our content etc.,
SAGE works towards ensuring all experiences with us would be a satisfactory and rewarding one.
Company website: www.sagepublications.com <http://www.sagepublications.com

NO.22
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
Shanghai Hengrui Pharmaceuticals Co., Ltd is a fully integrated drug discovery company dedicated to discovery of New Chemical Entities (NCEs).
We have many scientists in all areas of drug discovery: Synthetic organic chemistry, Medicinal chemistry, Parallel chemistry, Analytical chemistry, Assay development, Screening operation, Chemo/Bio Informatics, Molecular biology, Cell biology, Protein purification, Animal modeling, BMPK, Toxicology, Formulation/Pre-formulation, QA/QC and Preclinical development.
We are conveniently located in Minhang Economic Zone, 30 minutes from the vibrant Shanghai downtown and occupy a new 20000 square meter laboratories equipped with state-of-art instruments.

NO.23
MicroConstants China Co., Ltd.
MicroConstants is a global leader in providing high quality DMPK and bioanalytical contract services to pharmaceutical and biotech companies worldwide. MicroConstants have ten years history of USFDA and OECD GLP compliance and have provided GLP bioanalytical support for over 500 drugs. MicroConstants have been successfully audited twice by USFDA.
Our services include: Bioanalytical method development/validation (ELISA, LC/MS/MS); Sample bioanalysis under FDA and OECD guidelines; GLP formulation analysis; DMPK studies; Toxicokinetics studies; Project management for toxicology and clinical studies.

NO.24
DL Instrument, Inc.
DL Instruments, Inc. is the leading provider of automated and traditional patch clamp devices in China. We also provide other electrophysiological devices and imaging, animal behavior instruments. We represent a wide range of quality products manufactured by many of the world’s leading companies in the life science field, such as HEKA, Sophion, Sutter, etc. Our sales team consists of more than 20 experienced sales engineers in China. We have at least two training courses for patch clampers in China every year. We have a strong technical support group to help our customers with any problems. We pride ourselves on the excellence of our after-sale service.